A carefully chosen annual panel, tracked over time, may offer a clearer picture of cardiovascular, metabolic and hormonal health than wearable data alone.
Routine blood testing remains one of the most useful ways to spot hidden health risks before they become symptoms, and a recent biohacking guide argues that a carefully chosen annual panel can do more for long-term health than a drawer full of wearables. The article, published by The Biohack, says the real value lies in trend lines rather than single readings: fasting, morning samples taken when the body is rested can provide a baseline for cardiovascular, metabolic, hormonal and nutritional health that is hard to get from day-to-day tracking alone.
The strongest case in the guide is for cardiovascular risk testing, particularly apolipoprotein B, or ApoB, and lipoprotein(a), known as Lp(a). ApoB reflects the number of atherogenic particles in the blood and can be more informative than LDL cholesterol on its own, while Lp(a) is largely inherited and usually unaffected by lifestyle changes. That emphasis is broadly consistent with the American College of Cardiology and the American Heart Association, which in March released an updated dyslipidaemia guideline recommending that adults have Lp(a) measured at least once in their lives, alongside attention to LDL-C targets tailored to risk.
The same guideline also restores a more detailed risk-based approach to cholesterol management. The ACC and AHA said adults should undergo universal lipid screening from age 19, with repeat testing every five years, and they highlighted the use of extra markers to refine risk assessment. In practice, that means a standard lipid panel is still important, but it is increasingly viewed as only one part of the picture, especially for people with high triglycerides, low HDL cholesterol or a family history of premature heart disease.
On the metabolic side, the article argues that HbA1c, fasting glucose and fasting insulin can reveal insulin resistance well before diabetes develops. That is a sensible point: HbA1c gives a longer-term view of blood sugar, while fasting insulin may uncover compensation by the pancreas before glucose levels rise. The piece also places high-sensitivity C-reactive protein, or hs-CRP, on the core list, noting that persistent inflammation is associated with higher cardiovascular risk and can be temporarily distorted by illness or hard exercise.
The guide then turns to hormones, recommending thyroid testing with both thyroid-stimulating hormone and free T4, rather than relying on TSH alone. It also suggests morning testosterone testing for men, with repeat confirmation if results are low, and cycle-aware estradiol and progesterone testing for women who want a baseline before perimenopause. Beyond hormones, it makes a case for vitamin D, vitamin B12, homocysteine, a comprehensive metabolic panel and a complete blood count as practical, relatively inexpensive checks on nutritional status and organ function.
Where the article is more cautious is on biological age tests. Epigenetic clocks and similar commercial assays can be intriguing, but the piece says they are not yet sufficiently actionable to replace conventional biomarkers. That is a prudent distinction. For now, the clearest value still lies in established tests repeated consistently over time, with any abnormal result rechecked after an intervention and interpreted with a doctor who understands prevention rather than simply responding to flags on a screen.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
